Lorundrostat hydrobromide clinical trials
A product of Lorundrostat; its studies count on that page too.
How each study uses lorundrostat hydrobromide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the lorundrostat hydrobromide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- MT-4129
- 1
Studies by the year they started
3 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2021 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Mineralys Therapeutics Inc. (1) · Mitsubishi Tanabe Pharma Corporation (1) · MycoMedica Life Sciences PBC (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Lorundrostat
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test lorundrostat hydrobromide.
- Sep 2027MLS101 Study in PMDDPhase 1 · MycoMedica Life Sciences PBC
Studies
Open first, then newest update. How each study uses lorundrostat hydrobromide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- MLS101 Study in PMDDNot yet recruitingPhase 1MycoMedica Life Sciences PBCNCT07818720Written as MLS101 psilocybin
- Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled HypertensionCompletedPhase 2Mineralys Therapeutics Inc.NCT05001945Written as MLS-101 (Part I)
- A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy VolunteersCompletedPhase 1Mitsubishi Tanabe Pharma CorporationNCT02953132Written as MT-4129
Codes
What other systems call lorundrostat hydrobromide · ClinicalTrials.gg INT014471
- UNII (FDA) 2F9CF7C3PSLORUNDROSTAT HYDROBROMIDEOne source FDA
- NCI Thesaurus C204144Lorundrostat HydrobromideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2F9CF7C3PS | LORUNDROSTAT HYDROBROMIDE | One source FDA |
| NCI Thesaurus | C204144 | Lorundrostat Hydrobromide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.